Moa Life Plus

Moa Life Plus EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Moa Life Plus (142760.KQ) as of Oct 30, 2026 is -7.13. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -9.56 — a change of -25.41% (higher).

EV/FCF

-7.13

YoY

-25.41%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Moa Life Plus is 2025 -7.13 . EV/FCF (Enterprise Value to Free Cash Flow) of Moa Life Plus was 2024 -9.56 . It decreases by -25.41% higher compared to the previous year.

The Moa Life Plus EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-0.86 KRW
Jan 1, 2019
-0.74 KRW
Jan 1, 2020
-1.78 KRW
Jan 1, 2021
-2.79 KRW
Jan 1, 2022
-1.92 KRW
Jan 1, 2023
4.89 KRW
Jan 1, 2024
-9.56 KRW
Jan 1, 2025
-7.13 KRW
The Moa Life Plus EV/FCF history
YEAREV/FCFYoY
-7.13-25.41%
-9.56-295.49%
4.89-354.98%
-1.92-31.25%
-2.79+56.97%
-1.78+139.17%
-0.74-13.55%
-0.86-47.51%
-1.64-47.87%
-3.14-57.90%
-7.46-36.09%
-11.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

EV/FCF (Enterprise Value to Free Cash Flow) of Moa Life Plus is -7.13 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Moa Life Plus changed from -9.56 to -7.13, representing a -25.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Moa Life Plus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Moa Life Plus

All Key Metrics — Moa Life Plus